Turner DP - Search Results

1

Slug expression enhances tumor formation in a noninvasive rectal cancer model.

Camp ER, Findlay VJ, Vaena SG, Walsh J, Lewin DN, Turner DP, Watson DK. Camp ER, et al. Among authors: turner dp. J Surg Res. 2011 Sep;170(1):56-63. doi: 10.1016/j.jss.2011.02.012. Epub 2011 Mar 23. J Surg Res. 2011. PMID: 21470622 Free PMC article.

2

Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.

Turner DP, Moussa O, Sauane M, Fisher PB, Watson DK. Turner DP, et al. Cancer Res. 2007 Feb 15;67(4):1618-25. doi: 10.1158/0008-5472.CAN-06-2913. Cancer Res. 2007. PMID: 17308102

3

Defining ETS transcription regulatory networks and their contribution to breast cancer progression.

Turner DP, Findlay VJ, Moussa O, Watson DK. Turner DP, et al. J Cell Biochem. 2007 Oct 15;102(3):549-59. doi: 10.1002/jcb.21494. J Cell Biochem. 2007. PMID: 17661355 Review.

4

ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer.

Turner DP, Watson DK. Turner DP, et al. Expert Rev Anticancer Ther. 2008 Jan;8(1):33-42. doi: 10.1586/14737140.8.1.33. Expert Rev Anticancer Ther. 2008. PMID: 18095881 Review.

5

Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.

Turner DP, Findlay VJ, Kirven AD, Moussa O, Watson DK. Turner DP, et al. Mol Biol Cell. 2008 Sep;19(9):3745-57. doi: 10.1091/mbc.e08-02-0154. Epub 2008 Jun 25. Mol Biol Cell. 2008. PMID: 18579687 Free PMC article.

6

MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.

Findlay VJ, Turner DP, Moussa O, Watson DK. Findlay VJ, et al. Among authors: turner dp. Cancer Res. 2008 Oct 15;68(20):8499-506. doi: 10.1158/0008-5472.CAN-08-0907. Cancer Res. 2008. PMID: 18922924 Free PMC article.

7

PDEF is a negative regulator of colon cancer cell growth and migration.

Moussa O, Turner DP, Feldman RJ, Sementchenko VI, McCarragher BD, Desouki MM, Fraig M, Watson DK. Moussa O, et al. Among authors: turner dp. J Cell Biochem. 2009 Dec 15;108(6):1389-98. doi: 10.1002/jcb.22371. J Cell Biochem. 2009. PMID: 19830706 Free PMC article.

8

Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.

Schaefer JS, Sabherwal Y, Shi HY, Sriraman V, Richards J, Minella A, Turner DP, Watson DK, Zhang M. Schaefer JS, et al. Among authors: turner dp. J Biol Chem. 2010 Apr 9;285(15):11258-69. doi: 10.1074/jbc.M109.073932. Epub 2010 Feb 5. J Biol Chem. 2010. PMID: 20139077 Free PMC article.

9

Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.

Turner DP, Findlay VJ, Moussa O, Semenchenko VI, Watson PM, LaRue AC, Desouki MM, Fraig M, Watson DK. Turner DP, et al. Prostate. 2011 Dec;71(16):1723-35. doi: 10.1002/pros.21389. Epub 2011 Mar 28. Prostate. 2011. PMID: 21446014 Free PMC article.

10

Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms.

Findlay VJ, Turner DP, Yordy JS, McCarragher B, Shriver MR, Szalai G, Watson PM, Larue AC, Moussa O, Watson DK. Findlay VJ, et al. Among authors: turner dp. Genes Cancer. 2011 Feb;2(2):120-9. doi: 10.1177/1947601911410424. Genes Cancer. 2011. PMID: 21779485 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters